Document Detail


Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis.
MedLine Citation:
PMID:  19423834     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In advanced cirrhosis, decreased lung transfer for carbon monoxide (TLCO) and increased alveolar-arterial oxygen tension difference (PA-aO(2) >or=15 mmHg while breathing ambient air) are frequently detected. Pulmonary membrane diffusion capacity for CO (DmCO) and pulmonary capillary blood volume (Vcap) can be derived from the simultaneous measurement of TLCO and lung transfer for nitric oxide (TLNO). Measurements of single-breath TLNO and TLCO were performed in 49 cirrhotic patients with advanced liver cirrhosis and in 35 healthy controls to derive Vcap, DmCO, and TLNO:TLCO ratio. Twenty-five patients had increased PA-aO(2), of whom 11 had hepatopulmonary syndrome (HPS). Compared with controls, non-HPS patients with normal PA-aO(2) had a significant approximately 10% decrease in TLCO, DmCO, and Vcap but similar TLNO:TLCO ratios. Compared with non-HPS patients with normal PA-aO(2), non-HPS patients with increased PA-aO(2) had lower Vcap and higher TLNO:TLCO ratio but similar DmCO. HPS patients had lower Vcap and higher TLNO:TLCO ratios than both subgroups of non-HPS patients. In cirrhotic patients, TLNO:TLCO ratios correlated positively, and TLCO (percentage of the predicted value) and Vcap (percentage of the predicted value) correlated negatively with PA-aO(2) (r(2) = 0.25, P = 0.0003, r(2) = 0.48, P < 0.0001 and r(2) = 0.57, P < 0.0001, respectively). We concluded that, in cirrhotic patients, lower TLCO and increased PA-aO(2) are associated with lower Vcap. In addition, high TLNO:TLCO ratios in patients with increased PA-aO(2) suggest a decreased thickness of the capillary blood layer in these patients.
Authors:
Bruno Degano; Marie Mittaine; Hervé Guénard; Jacques Rami; Gilles Garcia; Nassim Kamar; Christophe Bureau; Jean-Marie Péron; Lionel Rostaing; Daniel Rivière
Related Documents :
18019724 - Treatment of budd-chiari syndrome by transjugular intrahepatic portosystemic shunt.
20860634 - Non-alcoholic cirrhosis and the risk of stroke: a 5-year follow-up study.
19455124 - Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a p...
11204934 - Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis.
22891694 - Renal tubular acidosis type iv in hyperkalaemic patients a fairy tale or reality?
20021704 - Starch-entrapped microspheres show a beneficial fermentation profile and decrease in po...
Publication Detail:
Type:  Journal Article     Date:  2009-05-07
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  107     ISSN:  8750-7587     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-01     Completed Date:  2009-08-28     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol (1985)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  139-43     Citation Subset:  IM    
Affiliation:
Service de Pneumologie, Hôpital Antoine-Béclère, 157 rue de la Porte de Trivaux, 92141 Clamart, France. degano.b@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carbon Monoxide / metabolism*
Female
Humans
Liver Cirrhosis / metabolism*,  physiopathology*
Lung
Male
Middle Aged
Nitric Oxide / metabolism*
Pulmonary Diffusing Capacity / physiology*
Spirometry
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 630-08-0/Carbon Monoxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improved predictive models for plasma glucose estimation from multi-linear regression analysis of ex...
Next Document:  Leg exoskeleton reduces the metabolic cost of human hopping.